BioCentury | Aug 25, 2020
Management Tracks

Former head of gRED Varney joining Erasca; plus AAM, City of Hope, Immunovant, Kura, Illumina and more

...million series B round led by Morningside Ventures in July to advance its clinical plan for AMX0035...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...than 15 other investors, mostly undisclosed, participated as well. The funds will help Amylyx advance AMX0035...
...trial of AMX0035 to treat AD, and build internal capabilities including staffing. PEGASUS is testing AMX0035...
...five candidates. AMX0035 was not among them. Amylyx said it is “not the intention” for AMX0035...
BioCentury | Aug 16, 2017
Clinical News

Amylyx begins Phase II of AMX0035 for ALS

...Amylyx Pharmaceutical Corp. (Cambridge, Mass.) began the Phase II CENTAUR trial to evaluate twice-daily oral AMX0035...
...blood and imaging biomarkers, slow vital capacity (SVC) and rates of survival, tracheostomy and hospitalization. AMX0035...
...a combination of sodium phenylbutyrate and tauroursodeoxycholic acid. Amylyx Pharmaceutical Corp. , Cambridge, Mass. Product: AMX0035...
Items per page:
1 - 3 of 3